6652.TWO | Eusol Biotech Co.,Ltd. Annual & Quarterly

Annual Income Statements

(In TWD)

Breakdown	2023	2022	2021	2020	2019
Revenue	-	-	-	-	-
Cost of Revenue	4.02 Million	-	-	-	-
Gross Profit	-4.02 Million	-	-	-	-
Operating Expenses	41.48 Million	76.75 Million	122.77 Million	114.24 Million	108.74 Million
Selling, General and Administrative Expenses	16.72 Million	24.38 Million	24.89 Million	21.65 Million	24.57 Million
Research and Development Expenses	24.76 Million	52.37 Million	97.87 Million	92.58 Million	89.41 Million
Other Expenses	-	62.68 Million	-1.31 Million	343 Thousand	-
Cost and Expenses	41.48 Million	76.75 Million	122.77 Million	114.24 Million	108.74 Million
Operating Income	-41.48 Million	-12.07 Million	-123.36 Million	-113.36 Million	-113.98 Million
Interest Expense	142 Thousand	218 Thousand	217 Thousand	138 Thousand	-
Income Tax Expense	2.49 Million	6.02 Million	-271 Thousand	271 Thousand	-
Earnings before Tax	-49.12 Million	-12.28 Million	-123.58 Million	-113.49 Million	-107.25 Million
Net Income	-51.61 Million	-18.31 Million	-123.3 Million	-113.77 Million	-107.25 Million
Earnings Per Share Basic	-0.38	-0.13	-0.92	-0.91	-0.86
Earnings Per Share Diluted	-0.38	-0.13	-0.92	-0.91	-0.86
Weighted Average Shares Outstanding	137 Million	137 Million	134.04 Million	125 Million	125 Million
Weighted Average Shares Outstanding (Diluted)	135.82 Million	137 Million	134.04 Million	125 Million	125 Million
Gross Margin	-	-	-	-	-
EBIT Margin	-	-	-	-	-
Profit Margin	-	-	-	-	-
EBITDA	-44.95 Million	11.12 Million	-95.15 Million	-83.95 Million	-89.93 Million
Earnings Before Tax Margin	-	-	-	-	-

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Revenue	-	-	-	-	-	-
Cost of Revenue	1.78 Million	-	-	-	-	-
Gross Profit	-1.78 Million	-	-	-	-	-
Operating Expenses	10.28 Thousand	10.28 Thousand	16.72 Thousand	41.48 Million	16.72 Thousand	10.08 Thousand
Selling, General and Administrative Expenses	4191.50	4191.50	4144.00	-	4144.00	4216.50
Research and Development Expenses	6460.50	6460.50	6348.50	-	6348.50	6032.00
Other Expenses	-	-	-	-12.13 Million	-	-
Cost and Expenses	10.28 Thousand	10.28 Thousand	16.72 Thousand	41.48 Million	16.72 Thousand	10.08 Thousand
Operating Income	-10.65 Thousand	-10.65 Thousand	-10.49 Thousand	-48.98 Million	-10.49 Thousand	-10.24 Thousand
Interest Expense	-	-	-	142 Thousand	-	-
Income Tax Expense	1183.00	1183.00	1183.50	2.49 Million	1183.50	62.00
Earnings before Tax	-9046.00	-9046.00	-15.53 Thousand	-49.12 Million	-15.53 Thousand	-9022.00
Net Income	-7.86 Million	-7.86 Million	-16.72 Million	-51.61 Million	-16.72 Million	-9.08 Million
Earnings Per Share Basic	-0.06	-0.06	-0.12	-	-0.12	-0.07
Earnings Per Share Diluted	-0.06	-0.06	-0.12	-	-0.12	-0.07
Weighted Average Shares Outstanding	142.96 Million	142.96 Million	137 Million	135.82 Million	137 Million	137 Million
Weighted Average Shares Outstanding (Diluted)	142.96 Million	142.96 Million	137 Million	135.82 Million	137 Million	137 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-9757.50	-9757.50	-10.19 Thousand	-	-10.19 Thousand	-9734.50
Earnings Before Tax Margin	-	-	-	-	-	-